Abstract
Enthesitis related arthritis (ERA) is a subcategory of juvenile idiopathic arthritis (JIA) which primarily affects peripheral joints and entheses but also can involve the sacroiliac joints and spine. It causes long-term effects on both physical and quality aspects of a child's life. Adalimumab (ADA) has been previously demonstrated to be effective in polyarticular JIA.
Highlights
Enthesitis related arthritis (ERA) is a subcategory of juvenile idiopathic arthritis (JIA) which primarily affects peripheral joints and entheses and can involve the sacroiliac joints and spine
Active disease was defined as ≥3 active joints and enthesitis in ≥1 location
Safety was assessed in terms of adverse events (AE)
Summary
Enthesitis related arthritis (ERA) is a subcategory of juvenile idiopathic arthritis (JIA) which primarily affects peripheral joints and entheses and can involve the sacroiliac joints and spine. It causes long-term effects on both physical and quality aspects of a child’s life. Adalimumab (ADA) has been previously demonstrated to be effective in polyarticular JIA
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
